Home/Filings/4/0001818382-24-000058
4//SEC Filing

Binder Gordon M 4

Accession 0001818382-24-000058

CIK 0001818382other

Filed

May 14, 8:00 PM ET

Accepted

May 15, 7:24 PM ET

Size

7.1 KB

Accession

0001818382-24-000058

Insider Transaction Report

Form 4
Period: 2024-05-15
Transactions
  • Purchase

    Common Stock

    2024-05-15$6.78/sh+50,000$339,000160,000 total
  • Purchase

    Common Stock

    2024-05-15$6.57/sh+50,000$328,50050,000 total(indirect: By Trust)
Footnotes (2)
  • [F1]The price is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $6.44 to $6.59. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  • [F2]The price is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $6.64 to $6.96. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Issuer

Humacyte, Inc.

CIK 0001818382

Entity typeother

Related Parties

1
  • filerCIK 0001291957

Filing Metadata

Form type
4
Filed
May 14, 8:00 PM ET
Accepted
May 15, 7:24 PM ET
Size
7.1 KB